Apoptosis and progression of hepatic fibrosis in liver diseases;Apoptosis y progresión de fibrosis hepática en enfermedades del hígado

Acta Gastroenterologica Latinoamericana

Volumn 36, Issue 4, 2006, Pages 211-217

  Schinoni, María I ^a,b   Paraná, Raymundo ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b NONE   (Brazil)

Author keywords

Apoptosis; Liver fibrosis and disease

Indexed keywords

TNFRSF10A PROTEIN, HUMAN; TNFRSF10B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL; APOPTOSIS; DISEASE COURSE; FIBROSIS; HUMAN; LIVER CELL; LIVER DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; APOPTOSIS; DISEASE PROGRESSION; FIBROSIS; HEPATOCYTES; HUMANS; LIVER DISEASES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 33845372941     PISSN: 03009033     EISSN: 03009033     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Kaplowitz N. Hepatology: A century of progress. Cell death at the millennium. Clinics in Liver Disease 2000;4:257-268.
2. Patel T. Apoptosis en hepatic pathophisiology. Clinics in Liver Disease 2000;4:295-317.
3. Yoon J.H, Gores G. Death receptor-mediated apoptosis and the liver. Journal of Hepatology 2002;37:400-410.
4. Canbay A, Friedman S, Gores G. Apoptosis: The nexus of liver injury and Fibrosis, Hepatology. 2004;39:273-278.
5. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-1312.
6. Seino K, Setoguchi Y, Ogino T, Kayagaki N, Akiba H, Nakano H, Taniguchi H, Takada Y, Yuzawa K, Todoroki T, Fukuchi Y, Yagita H, Okumura K, Fukao K. Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappa B activation. Annals of Surgery 2001;234:681-688.
7. Bantel H, Lugering A, Poremba C, Bantel H, Lugering A, Poremba C, Lugering N, Held J, Domschke W, Schulze-Osthoff K. Caspase activation correlates with the degree of infkmatory liver injury in Chronic Hepatitis C Virus infection. Hepatology 2001;34:758-767.
8. Prikod "ko E, Prikod" ko G, Siegel R, Thompson P, Major M, Cohen J. The NS3 protein of hepatitis C virus induces caspase-8-mediated apoptosis independent of its proteases or helicases activities. Virology 2004;329:53-67.
9. Ogasawara K, Hida S, Azimi N, Ogasawara K, Hida S, Azimi N, Tagaya Y, Sato T, Yokochi-Fukuda T, Waldmann TA, Taniguchi T, Taki S. Lethal effect of the anti-Fas antibody in mice. Nature 1998; 391:700-703.
10. Nanji, A. Apoptosis and alcoholic liver disease. Seminars in Liver Disease 1998;18:187-190.
11. Pianko S, Patella S, Ostapowicz G, Desmond P, Sievert, W. Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection. Journal of Viral Hepatitis 2001;8:406-413.
12. Higuchi H, Bronk S.F, Takikawa Y, Werneburg N, Takimoto R, El-Deiry W, Gores GJ. The bile acid gylcochenodeoxycholate induces trail receptor 2/ Dr 5 expression and apoptosis. The Journal of Biological Chemistry 2001;276:38610-38618.
13. Fadok VA., Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/ paracrine mechanismms involving TFG-beta, PGE2, and PAF. The Journal of Clinical Investigation 1998;101:890-898.
14. Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. Journal of hepatology 2001;34:248-253.
15. Shimamatsu K, Wanless I.R. Role of ischemia in causing apoptosis, atrophy and nodular hyperplasia in human liver. Hepatology 1997;26:343-350.
16. Schulze-Osthoff K., Ferrari D, Los M, Wesselborg S, Peter M.E. Apoptosis signaling by death receptors. European Journal of Biochemistry 1998;254:439-459.
17. Me Partland J, Guzail M, Kendall C, Pringle J. Apoptosis in chronic viral hepatitis paralles histological activity: An immunohistochemical investigation using anti-activated caspase 3 and M30 Cytodeath antibody. International Journal of Experimental Pathology 2005;86:19-24.
18. Kountouras J, Zavos C, and Chatzopoulos D. Apoptosis in Hepatitis C. Journal of Viral Hepatitis 2003;10:335-342.